National Health Investors (NHI) Issues FY18 Earnings Guidance

National Health Investors (NYSE:NHI) issued an update on its FY18 earnings guidance on Tuesday morning. The company provided EPS guidance of $5.47-5.51 for the period, compared to the Thomson Reuters consensus EPS estimate of $5.51. National Health Investors also updated its FY 2018 guidance to $3.73-3.75 EPS.

NHI stock traded down $1.22 during midday trading on Tuesday, reaching $72.97. The company had a trading volume of 1,031 shares, compared to its average volume of 195,950. The company has a quick ratio of 15.56, a current ratio of 15.56 and a debt-to-equity ratio of 0.90. National Health Investors has a fifty-two week low of $62.71 and a fifty-two week high of $81.60. The company has a market cap of $3.08 billion, a P/E ratio of 13.61, a PEG ratio of 3.13 and a beta of 0.30.

National Health Investors (NYSE:NHI) last issued its quarterly earnings data on Tuesday, August 7th. The real estate investment trust reported $0.91 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.96 by ($0.05). The business had revenue of $72.96 million for the quarter, compared to analyst estimates of $73.80 million. National Health Investors had a return on equity of 11.49% and a net margin of 53.16%. Analysts expect that National Health Investors will post 5.51 EPS for the current fiscal year.

A number of research firms have weighed in on NHI. Wells Fargo & Co restated a hold rating on shares of National Health Investors in a research report on Tuesday, August 28th. Zacks Investment Research downgraded National Health Investors from a buy rating to a hold rating in a research report on Tuesday, August 14th. Cantor Fitzgerald upped their target price on National Health Investors from $75.00 to $80.00 and gave the stock a neutral rating in a research report on Wednesday, August 8th. SunTrust Banks restated a hold rating and issued a $79.00 target price on shares of National Health Investors in a research report on Wednesday, August 8th. They noted that the move was a valuation call. Finally, Stifel Nicolaus set a $83.00 target price on National Health Investors and gave the stock a buy rating in a research report on Tuesday, August 7th. One research analyst has rated the stock with a sell rating, six have assigned a hold rating and five have issued a buy rating to the company. The stock has an average rating of Hold and a consensus target price of $75.22.

TRADEMARK VIOLATION WARNING: “National Health Investors (NHI) Issues FY18 Earnings Guidance” was first posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this article on another site, it was illegally stolen and reposted in violation of United States & international trademark and copyright laws. The original version of this article can be accessed at https://www.dispatchtribunal.com/2018/11/06/national-health-investors-nhi-issues-fy18-earnings-guidance.html.

National Health Investors Company Profile

Incorporated in 1991, National Health Investors, Inc (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals.

Recommended Story: Why is the conference call important?

Earnings History and Estimates for National Health Investors (NYSE:NHI)

Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply